Sign in

LIFE on Nasdaq

Life Technologies

Logo: Unknown author Unknown author, Public domain, via Wikimedia Commons6

Biotech company

Life Technologies Corporation was a biotech company founded in November 2008 through a US $6.7 billion merger of Invitrogen Corporation and Applied Biosystems Inc. The joint sales of the combined companies were about $3.5 billion; they had about 9,500 employees and owned more than 3,600 licenses and patents.3 It is part of Thermo Fisher Scientific Inc.1 Wikipedia text CC BY-SA 4.0

$38.38 down 0.58 (1.50%)Price as of Oct 15, 2026 at 17:33 UTC

Last updated Oct 21, 2026.

Overview

$387.6MRevenue, fiscal 20257
$71.2MNet income, fiscal 20257
2008Founded1

Compare with Goosehead Insurance, Inc., eHealthInsurance or Waterdrop Inc., or pick any stock.

  • TickerLIFE on Nasdaq1
  • IndustryInsurance Agents, Brokers & Service1
  • HeadquartersCarlsbad1
  • Websitewww.lifetechnologies.com
  • Legal formDelaware corporation1
  • Incorporated inDE8
  • Business address1606 Headway Circle, #9013, Austin, Tx 787548
  • Filer category, Emerging growth company8
  • LEIZX5LQJBHZ3NFEMZ34U074
  • StatusActive4
  • LEI statusLapsed (not renewed)4
  • Registered addressc/o CAPITOL SERVICES, INC., 19901 Dover, United States4
  • Registered withDivision of Corporations, Department of State, 27534314

See how the biggest companies compare on our leaderboards

Life Technologies Corporation was a biotech company founded in November 2008 through a US $6.7 billion merger of Invitrogen Corporation and Applied Biosystems Inc. The joint sales of the combined companies were about $3.5 billion; they had about 9,500 employees and owned more than 3,600 licenses and patents.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

18.8%Operating margin7
18.4%Net margin7
52.0%Revenue growth, 20257
$34.7MFree cash flow7

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue2¢$6.7M
  • Other costs79¢$305.1M
  • Income tax1¢$4.6M
  • Profit18¢$71.2M

Out of $387.6M in revenue.7

Where each dollar of operating cash went, fiscal 2025

  • Capital spending4¢$1.5M
  • Kept or used elsewhere96¢$34.7M

Out of $36.2M of cash from operations.7

Financial statements

Revenue7$387.6M in 2025+52% since 2024
0$100.0M$200.0M$300.0M$400.0M2024: $254.9M$254.9M20242025: $387.6M$387.6M2025+52%
Operating income7$72.9M in 2025+50% since 2024
0$20.0M$40.0M$60.0M$80.0M2024: $48.7M$48.7M20242025: $72.9M$72.9M2025+50%
Net income7$71.2M in 2025+46% since 2024
0$20.0M$40.0M$60.0M$80.0M2024: $48.8M$48.8M20242025: $71.2M$71.2M2025+46%

Every line of the income statement as filed: the last 2 fiscal years, latest first.7

Period ending2025-12-312024-12-31
Commission$387.6M$254.9M
Total revenue$387.6M$254.9M
Sales and marketing$229.3M$148.7M
General and administrative$39.6M$22.4M
Technology (exclusive of amortization)$33.6M$23.1M
Cost of revenue$6.7M$6.5M
Depreciation and amortization$5.4M$5.4M
Total costs and expenses$314.7M$206.2M
Income from operations$72.9M$48.7M
Interest expense-$3.2M-$595.0K
Interest income$5.8M$5.6M
Other income, net$161.0K$185.0K
Total other income (expense), net$2.8M$5.2M
Net income before income tax expense$75.7M$53.9M
Income tax expense-$4.6M-$5.1M
Net income$71.2M$48.8M
Change in unrealized gain (loss) on marketable securities$253.0K-$121.0K
Unrealized foreign currency translation loss-$329.0K-$199.0K
Total other comprehensive income (loss)-$76.0K-$320.0K
Comprehensive income$71.1M$48.5M
Basic net income per share$4.31$3.05
Diluted net income per share$1.22$0.85
Weighted-average shares used in computing basic net income per share16.5M shares16.0M shares
Weighted-average shares used in computing diluted net income per share58.4M shares57.6M shares

Compare Life Technologies with another company

Corporate structure

Life Technologies is part of a group headed by Thermo Fisher Scientific Inc.. 1,172 entities, 39 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Life Technologies

  • Thermo Fisher Scientific Inc. Waltham, Massachusetts, United States
    • Life Technologies 100% · Carlsbad, California, United States
      • INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED Subsidiary · Bangalore, India
    • FEI Company Waltham, Massachusetts, United States
    • Alfa Aesar Subsidiary · Haverhill
    • Brahms Subsidiary · Hennigsdorf, Germany
    • Invitrogen Subsidiary · Carlsbad
    • Molecular Probes Subsidiary · Eugene
    • Pierce Biotechnology Subsidiary · Waltham
    • Thermo Electron Subsidiary · Waltham
      • Thermo Optek Subsidiary · United States
    • Thermo Fisher (Israel) Subsidiary · Ness Ziona, Israel
    • Thermo Fisher Scientific (Finland) Subsidiary · Vantaa, Finland
    • Thermo Fisher Scientific (Germany) Subsidiary · Dreieich, Germany
    • Thermo Fisher Scientific (Sweden) Subsidiary · Uppsala, Sweden
    • Thermo Fisher Scientific Baltics, UAB Subsidiary · Vilnius
    • 0972792 B.C. LTD Subsidiary · Canada
    • 236 Perinton Parkway, LLC Subsidiary · New York, United States
    • 27 Forge Parkway LLC Subsidiary · Delaware, United States
    • Abgene Inc. Subsidiary · Delaware, United States
    • ABII 2 Limited Subsidiary · United Kingdom
    • ACI Holdings Inc. Subsidiary · New York, United States
    • Acoustic Cytometry Systems, Inc. Subsidiary · Delaware, United States
    • AcroMetrix LLC Subsidiary · California, United States
    • Acros Organics Subsidiary · Geel, Belgium
    • Acurian, Inc. Subsidiary · Delaware, United States
    • Advanced Biotechnologies Limited Subsidiary · United Kingdom
    • Advanced Scientifics International, Inc. Subsidiary · Pennsylvania, United States
    • and 1,150 more

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; subsidiaries, stakes and holdings from Wikidata (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Life Technologies reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Computer equipment and software$4.6M7 Dec 31, 2025$3.1M7 Dec 31, 2024+49.5%
Property and equipment, before depreciation$26.5M7 Dec 31, 2025$20.7M7 Dec 31, 2024+28.2%
Accumulated depreciation$18.3M7 Dec 31, 2025$13.3M7 Dec 31, 2024+38.2%
Property and equipment, net$8.2M7 Dec 31, 2025$7.4M7 Dec 31, 2024+10.3%
Operating-lease assets (leased space)$2.2M7 Dec 31, 2025$2.5M7 Dec 31, 2024−13.9%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$91.1M7 Dec 31, 2025$35.1M7 Dec 31, 2024+159.7%
Marketable securities, current$34.9M7 Dec 31, 2025$68.3M7 Dec 31, 2024−48.9%
Debt securities available for sale$66.3M7 Dec 31, 2025$103.3M7 Dec 31, 2024−35.8%
Long-term investments$31.5M7 Dec 31, 2025$35.0M7 Dec 31, 2024−10.1%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$2.2M7 Dec 31, 2025$2.2M7 Dec 31, 20240%
Intangible assets, net (excluding goodwill)$662.0K7 Dec 31, 2025$221.0K7 Dec 31, 2024+199.5%

Properties, in its own words

Our principal executive offices are in San Francisco, California, where we occupy approximately 9,000 square feet of office space pursuant to a lease expiring in November 2028. We currently also lease office space internationally in Bengaluru, India and Singapore. We do not own any real property. We believe that our current facilities are adequate to meet our current needs.

Item 2 of the 10-K filed Mar 17, 2026.12

Leadership

Who has led Life Technologies, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Gregory T. Lucier2006–2014
  2. Peter George Colis2026–now

Chair

  1. Gregory T. Lucier2006–2007

President

  1. Gregory T. Lucier2006
  2. Mark Stevenson2008–2014
  3. Nicolas Barthelemy2008–2010
  4. Bernd Brust2009–2011
  5. Ronald Asbury Andrews2012–2014

Chief financial officer

  1. David F. Hoffmeister2006–2014
  2. Christopher M. Capozzi2026–now

Chief operating officer

  1. Mark Stevenson2008–2014
2010201520202025
Board members and other officers (42)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive OfficerAnan Kashyap named Jan 24, 202263
  • Executive Officer, DirectorLingke Wang named Jan 24, 202263
  • DirectorKyle Doherty named Jan 24, 202263
  • DirectorNate Niparko named Jan 24, 202263

Subsidiaries and ownership

Parent company

From Wikidata.1

Acquisitions

Between its formation in 2008 and its acquisition by Thermo Fisher Scientific in 2014, Life Technologies Corporation was an independent multinational corporation based in Carlsbad, California, United States.

In 2013, they launched a project called Claritas Genomics in partnership with Boston Children's Hospital. With Children's as a major shareholder, Claritas Genomics merged the knowledge, resources, and employees of the Genetic Diagnostic Lab at the Boston hospital, a CLIA-certified facility that provided more than 100 genetic tests, including numerous specific diagnostics created at Boston Children's. It also made use of the Ion Proton Sequencer from Life Technologies, a precise benchtop device that might be scaled for widespread use in new assays.

Later, in 2013, Thermo Fisher agreed to buy Life Technologies for $13.6 billion.

From Wikipedia’s article on Life Technologies, shared under CC BY-SA 4.0.9

Timeline

  1. Oct 9, 20268-K Other events64
  2. Sep 16, 20268-K Regulation FD disclosure65
  3. Aug 3, 20268-K Results of operations; Other events66
  4. May 6, 20268-K Results of operations67
  5. Feb 25, 20268-K Results of operations68
  6. Feb 2, 20268-K Entered a material agreement; Bylaws or fiscal year changed69
  7. Jan 28, 2026New chief executive Peter George Colis becomes CEO13
  8. Feb 3, 2014Parent Directly consolidated by Thermo Fisher Scientific Inc.4
  9. Feb 3, 2014Acquired Acquired by Thermo Fisher Scientific Inc.1
  10. 2008Founded Founded1
  11. Mar 7, 2006New chief executive Gregory T. Lucier becomes CEO14

Calendar

Coming up

  1. Nov 2, 2026 · After the closeReports results for the quarter ending Sep/202670

When it reported results

  1. Aug 3, 2026Reported quarterly or annual results66
  2. May 6, 2026Reported quarterly or annual results67
  3. Feb 25, 2026Reported quarterly or annual results68

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

127 filings to the SEC since October 2021: 1 annual reports, 2 quarterly reports, 6 major events, 69 insider forms, 9 large holders, 1 private raises, 39 other. The latest 20:

  1. Oct 15, 2026144 EDGAR
  2. Oct 15, 2026144 EDGAR
  3. Oct 14, 2026144 EDGAR
  4. Oct 9, 20268-K EDGAR
  5. Sep 18, 20264 EDGAR
  6. Sep 18, 20264 EDGAR
  7. Sep 18, 2026144 EDGAR
  8. Sep 17, 2026144 EDGAR
  9. Sep 17, 2026144 EDGAR
  10. Sep 16, 2026144 EDGAR
  11. Sep 16, 20268-K EDGAR
  12. Sep 10, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  13. Sep 10, 20264 EDGAR
  14. Aug 25, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  15. Aug 25, 20264 EDGAR
  16. Aug 21, 20264 EDGAR
  17. Aug 21, 20264 EDGAR
  18. Aug 21, 2026144 EDGAR
  19. Aug 21, 20264 EDGAR
  20. Aug 21, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR

The 127 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

41 open-market trades by officers, directors and large owners since October 2021: 3 buys and 38 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Sep 18, 2026Colis Peter GeorgeCEO and SecretarySale23,333$36.85$859.8KForm 4
Sep 17, 2026Colis Peter GeorgeCEO and SecretarySale23,333$38.85$906.4KForm 4
Sep 17, 2026Wang LingkePresidentSale118,333$38.96$4.6MForm 4
Sep 16, 2026Colis Peter GeorgeCEO and SecretarySale23,334$39.82$929.1KForm 4
Aug 21, 2026Colis Peter GeorgeCEO and SecretarySale28,600$33.38$954.6KForm 4
Aug 20, 2026Colis Peter GeorgeCEO and SecretarySale27,924$32.93$919.6KForm 4
Aug 20, 2026Wang LingkePresidentSale118,333$33.29$3.9MForm 4
Aug 20, 2026Kucharski Brandt WalterChief Accounting OfficerSale8,735$32.47$283.7KForm 4
Aug 20, 2026SEQUOIA CAPITAL U.S. VENTURE FUND XV, L.P.10% ownerSale107,795$33.12$3.6MForm 4
Aug 20, 2026SC US (TTGP), LTD.10% ownerSale107,795$33.12$3.6MForm 4
Aug 19, 2026Colis Peter GeorgeCEO and SecretarySale27,924$33.00$921.5KForm 4
Aug 19, 2026SEQUOIA CAPITAL U.S. VENTURE FUND XV, L.P.10% ownerSale34,821$32.82$1.1MForm 4
Aug 19, 2026SC US (TTGP), LTD.10% ownerSale34,821$32.82$1.1MForm 4
Aug 17, 2026Colis Peter GeorgeCEO and SecretarySale29,342$34.18$1.0MForm 4
Aug 17, 2026Wang LingkePresidentSale22,623$34.28$775.6KForm 4
Aug 17, 2026Capozzi Christopher M.Chief Financial OfficerSale26,184$34.14$893.9KForm 4
Aug 17, 2026Kucharski Brandt WalterChief Accounting OfficerSale5,611$34.26$192.2KForm 4
Aug 14, 2026Kucharski Brandt WalterChief Accounting OfficerSale77,436$34.93$2.7MForm 4
Jul 28, 2026GV 2021, L.P.10% ownerSale118,138$18.90$2.2MForm 4
Jul 27, 2026GV 2021, L.P.10% ownerSale196,931$19.46$3.8MForm 4

All 41 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Jan 12, 2022Raised $7.5 million in a private offering of equity Form D: 52 investors so far Form D

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 71. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Alphabet Inc.3,622,604$65.7M0.1%−147,552
Softbank Group Corp.3,128,902$56.8M0.3%No change
Divisadero Street Capital Management, LP1,635,921$29.7M0.7%New
Capital World Investors1,315,789$23.9M0.0%No change
Glade Brook Capital Partners LLC857,862$15.6M0.6%−285,952
Vanguard Capital Management LLC487,570$8.8M0.0%+1,313
UBS Group AG417,412$7.6M0.0%−46,441
Cannell Capital LLC408,496$7.4M5.2%−43,841
Healthcare Of Ontario Pension Plan Trust Fund350,000$6.3M0.0%−350,000
Renaissance Technologies LLC342,500$6.2M0.0%+262,500
Manufacturers Life Insurance Company, The341,279$6.2M0.0%+533
Allspring Global Investments Holdings, LLC261,373$4.7M0.0%−3,509
Bard Associates Inc248,220$4.5M1.0%New
Federated Hermes, Inc.216,000$3.9M0.0%−167,844
Goldman Sachs Group Inc192,459$3.5M0.0%−300,039
Bank Of America Corp /de/180,482$3.3M0.0%New
BlackRock, Inc.172,399$3.1M0.0%−32,118
Two Sigma Investments, LP167,778$3.0M0.0%+45,987
Geode Capital Management, LLC135,108$2.5M0.0%−5,507
Lionhunter Capital Management, LLC128,000$2.3M1.0%New
Woodline Partners LP120,182$2.2M0.0%No change
Glynn Capital Management LLC119,143$2.2M0.6%New
Burkehill Global Management, LP100,000$1.8M0.1%No change
D. E. Shaw & Co., Inc.99,814$1.8M0.0%+69,814
General Catalyst Group Management, LLC74,179$1.3M0.7%No change

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How Life Technologies is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGAREthos Technologies Inc.2
  • CIK0001788451
  • Employer ID (EIN)81-318102412
  • Filer statusNon-accelerated filer an emerging growth company; not a smaller reporting company; not a shell company12
  • Incorporated inDelaware12
  • Fiscal year endsDecember 312
  • Industry code (SIC)6411 Insurance Agents, Brokers & Service2
  • SEC reviewing officeOffice of Finance, Division of Corporation Finance2
  • Business address1606 Headway Circle, #9013, Austin, TX 787542
  • Phone(415) 915-06652
  • Shares outstanding30,790,388 Common Class A shares; 32,079,265 Common Class B shares as of Feb 28, 202612
  • Public float$351.8M as of Jan 30, 202612
  • AuditorErnst & Young LLP, San Francisco, California PCAOB ID 42; no auditor attestation of internal control over financial reporting12
  • On EDGAR sinceSep 18, 20192
  • Filings131 in all: 4 (51), 144 (27), 3 (18), SCHEDULE 13G (8), 8-K (6), D (5), 10-Q (2), DRS/A (2)2
    All 18 form types

    S-1/A (2), S-8 (2), 10-K (1), 424B4 (1), 8-A12B (1), CERT (1), DRS (1), EFFECT (1), S-1 (1), SCHEDULE 13G/A (1)

  • Latest filingsAnnual report (10-K) Mar 17, 2026
    Quarterly report (10-Q) Aug 5, 2026
    Latest 8-K (8-K) Oct 9, 2026

Securities registered for trading

ClassSymbolExchange
Class A Common Stock, $0.0001 par valueLIFENasdaq

From the cover page of the 10-K filed Mar 17, 2026 (Section 12(b) of the Exchange Act).12

Risk factors and legal proceedings

The risks Life Technologies names in Item 1A of its 10-K filed Mar 17, 2026: 51 risks under these headings, as written.12

  • Risks Related to Our Business
  • We have a history of losses, and while we have recently achieved profitability, we may not sustain it in the future.
  • We have a limited history operating our business at its current scale, scope, and complexity, which makes it difficult to plan for future operations and growth initiatives and predict future results.
  • Our business could be harmed if we fail to manage our growth effectively.
  • Revenue we earn on the sale of insurance products is based on premiums set by carriers, and any meaningful change in these premiums, or any decrease in commission rates that we negotiate with our carriers based on such premiums, or actions by carriers seeking repayment of commissions, could adversely impact our revenue.
  • Our business may be harmed if we lose relationships with carriers, fail to maintain good relationships with carriers, become even more dependent upon a limited number of carriers or fail to develop new carrier relationships.
  • We rely on a limited number of carriers, and if we are unable to maintain these relationships or diversify the carriers with whom we work, our business and results of operations could be harmed.
  • We rely on a limited number of agency counterparties, and if we are unsuccessful in maintaining relationships with these and new agencies and their ultimate owners, our results of operations will be harmed.
  • Our success depends on individual agent adoption and engagement, and if agents do not engage with or adopt our platform, our results of operations will be harmed.
  • Our business depends in part on third-party data, technology, and infrastructure providers and failure to maintain these relationships or changes in their services could adversely affect our operations, revenue, and growth.
  • Competition in our industry is intense, and our inability to compete effectively may adversely affect our business, financial condition, and results of operations.
  • Cyber attacks, data breaches, security incidents, systems failures, and resulting interruptions in the availability of our websites, mobile applications, platform, or services could adversely affect our business, financial condition, and results of operations.
The other 40 risks
  • Our brand awareness and marketing efforts to help grow our business may not be effective.
  • We expect a number of factors to cause our results of operations and operating cash flows to fluctuate on a quarterly and annual basis, which may make it difficult to predict our future performance.
  • Changes in our accounting estimates and assumptions could negatively affect our financial position and operating results.
  • Our ability to recoup payments from agents and the timing of those recouped payments may impact our business and operating results.
  • Non-compliance with or changes in laws, regulations or licensing requirements applicable to us could restrict our ability to conduct our business and impact our results of operations and financial condition.
  • Fluctuations or an overall decline in economic activity, or any adverse trends in the life insurance industry, could have a material adverse effect on the financial condition and results of operations of our business.
  • Our inability to successfully recover should we experience a disaster or other business continuity problem could cause material financial loss, loss of human capital, regulatory actions, reputational harm or legal liability.
  • If we are unable to apply technology effectively in driving value for our consumers through technology-based solutions or gain internal efficiencies and effective internal controls through the application of technology and related tools, our operating results, consumer relationships, growth, and compliance programs could be adversely affected.
  • If we do not continue to innovate and further develop our platform, our platform developments do not perform, we do not successfully manage our platform strategy, or we are not able to keep pace with technological developments, we may not remain competitive and our business and results of operations could suffer.
  • Our inability to retain or hire qualified employees, as well as the loss of any of our executive officers, could negatively impact our ability to retain existing business and generate new business.
  • Any failure to offer high-quality support for our platform may harm our relationships with consumers, agents, and carriers and could adversely affect our business, financial condition, and results of operations.
  • We use third-party cloud service providers to deliver our platform services. Any disruption of services from our cloud service providers could harm our business.
  • Our business, financial condition, and results of operations may be negatively affected by E&O claims.
  • In connection with the implementation of our corporate strategies, we face risks associated with the acquisition or disposition of businesses, the entry into new lines of business, the integration of acquired businesses, and the growth and development of these businesses.
  • If we fail to improve and enhance the functionality, performance, reliability, design, security, and scalability of our platform and innovate and introduce new solutions in a manner that responds to our consumers’ evolving needs, our business may be adversely affected.
  • Our results may be adversely affected by changes in the mode of compensation in the insurance industry.
  • Internet search engines drive traffic to our platform and our new user growth could decline if we fail to appear prominently in search results.
  • Damage to our reputation could have a material adverse effect on our business.
  • Risks Related to Intellectual Property, Data Privacy, and Security
  • If our information technology systems or those of third parties with whom we work or our data, are or were compromised, we could experience adverse consequences resulting from such compromise, including regulatory investigations or actions, litigation, fines and penalties, disruptions of our business operations, reputational harm, loss of revenue or profits, loss of consumers or sales, and other adverse consequences.
  • We utilize artificial intelligence in connection with our business, which may expose us to regulatory, operational, or reputational risk.
  • Failure to obtain, maintain, protect, defend or enforce our intellectual property rights, the infringement, misappropriation, or other violation of our intellectual property by third parties, or allegations that we have infringed, misappropriated or otherwise violated the intellectual property rights of others, could harm our reputation, ability to compete effectively, financial condition, and business.
  • We employ third-party licensed software for use in our business, and the inability to maintain these licenses or errors in the software we license could result in increased costs or reduced service levels, which would adversely affect our business.
  • Our platform contains third-party open source software components, and failure to comply with the terms of the underlying open source software licenses could restrict our ability to provide our platform and services and subject us to costly litigation or other disputes.
  • Risks Related to Ownership of Our Common Stock
  • The dual class structure of our common stock as described in our amended and restated certificate of incorporation has the effect of concentrating voting control with those stockholders who held our stock prior to the closing of our initial public offering and limiting your ability to influence corporate matters, which could adversely affect the trading price of our Class A common stock.
  • Our stock price may be volatile, and the value of our Class A common stock may decline.
  • An active public trading market for our Class A common stock may not develop or be sustained.
  • Future sales of our Class A common stock in the public market could cause the market price of our Class A common stock to decline.
  • We may require additional capital to support the growth of our business, and this capital might not be available on acceptable terms, if at all.
  • We do not intend to pay dividends for the foreseeable future and, as a result, your ability to achieve a return on your investment will depend on appreciation in the price of our Class A common stock.
  • We are an “emerging growth company,” and the reduced reporting and disclosure requirements applicable to emerging growth companies could make our Class A common stock less attractive to investors.
  • We incur costs as a result of operating as a public company, and our management is required to devote substantial time to compliance with our public company responsibilities and corporate governance practices.
  • Anti-takeover provisions in our charter documents and under Delaware law could make an acquisition of our company more difficult, limit attempts by our stockholders to replace or remove our current management, and limit the market price of our Class A common stock.
  • Our amended and restated certificate of incorporation designates the Court of Chancery of the State of Delaware and the federal district courts of the United States of America as the exclusive forums for certain disputes between us and our stockholders, which restricts our stockholders’ ability to choose the judicial forum for disputes with us or our directors, officers, or employees.
  • If securities or industry analysts do not publish research or publish unfavorable or inaccurate research about our business, the market price and trading volume of our Class A common stock could decline.
  • General Risks
  • As a result of being a public company, we are obligated to develop and maintain proper and effective internal control over financial reporting, and any failure to maintain the adequacy of these internal controls may adversely affect investor confidence in our company and, as a result, the value of our Class A common stock.
  • We and our employees have and may continue to be subject to claims alleging violations of our employees’ contractual obligations to their prior employers. These claims may be costly to defend, and if we do not successfully do so, our business could be harmed.
  • Our ability to use our net operating losses to offset future taxable income may be subject to certain limitations.
  • We may be subject to additional tax liabilities, including as a result of changes in tax laws or regulations, which could adversely affect our financial condition and results of operations.
  • Our management team has limited experience managing a public company.
  • Climate risks, including the risk of an economic crisis, risks associated with the physical effects of climate change, and disruptions caused by the transition to a low-carbon economy, could adversely affect our business, results of operations and financial condition.

Legal proceedings

From time to time, we are involved in various legal proceedings arising from activities in the normal course of business. We are not presently a party to any litigation the outcome of which, we believe, if determined adversely to us, would individually or taken together have a material adverse effect on our business, financial condition, results of operations, and cash flows. Defending any legal proceeding is costly and can impose a significant burden on management and employees. The results of any current or future litigation cannot be predicted with certainty, and regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors.

The opening of Item 3, Legal Proceedings.12

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
    Yahoo FinanceLIFE quote
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
    SEC EDGAROther events
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71
  72. 72
  73. 73
  74. 74
  75. 75
  76. 76
  77. 77
  78. 78